These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 4986861

  • 21. Paranasal sinus pathogens in children with cystic fibrosis: do they relate to lower respiratory tract pathogens and is eradication successful?
    Wilson P, Lambert C, Carr SB, Pao C.
    J Cyst Fibros; 2014 Jul; 13(4):449-54. PubMed ID: 24713592
    [Abstract] [Full Text] [Related]

  • 22. Clinical profile of adult cystic fibrosis patients with frequent epidemic clones of Pseudomonas aeruginosa.
    Tingpej P, Elkins M, Rose B, Hu H, Moriarty C, Manos J, Barras B, Bye P, Harbour C.
    Respirology; 2010 Aug; 15(6):923-9. PubMed ID: 20573059
    [Abstract] [Full Text] [Related]

  • 23. Maintenance azithromycin treatment in pediatric patients with cystic fibrosis: long-term outcomes related to macrolide resistance and pulmonary function.
    Tramper-Stranders GA, Wolfs TF, Fleer A, Kimpen JL, van der Ent CK.
    Pediatr Infect Dis J; 2007 Jan; 26(1):8-12. PubMed ID: 17195698
    [Abstract] [Full Text] [Related]

  • 24. Pseudomonas aeruginosa in the home environment of newly infected cystic fibrosis patients.
    Schelstraete P, Van Daele S, De Boeck K, Proesmans M, Lebecque P, Leclercq-Foucart J, Malfroot A, Vaneechoutte M, De Baets F.
    Eur Respir J; 2008 Apr; 31(4):822-9. PubMed ID: 18094014
    [Abstract] [Full Text] [Related]

  • 25. [Efficacy and safety of cefepime in the treatment of bronchopulmonary disease exacerbation in pediatric patients with mucoviscidosis].
    Semykin SIu, Postnikov SS, Polikarpova SV, Dubovik LG, Kolbatova ES.
    Antibiot Khimioter; 2005 Apr; 50(4):18-22. PubMed ID: 16392335
    [Abstract] [Full Text] [Related]

  • 26. Successful decolonization of methicillin-resistant Staphylococcus aureus in paediatric patients with cystic fibrosis (CF) using a three-step protocol.
    Macfarlane M, Leavy A, McCaughan J, Fair R, Reid AJ.
    J Hosp Infect; 2007 Mar; 65(3):231-6. PubMed ID: 17178427
    [Abstract] [Full Text] [Related]

  • 27. Treatment intensity and characteristics of MRSA infection in CF.
    Muhlebach MS, Miller M, LaVange LM, Mayhew G, Goodrich JS, Miller MB.
    J Cyst Fibros; 2011 May; 10(3):201-6. PubMed ID: 21420912
    [Abstract] [Full Text] [Related]

  • 28. Pseudomonas aeruginosa population diversity and turnover in cystic fibrosis chronic infections.
    Mowat E, Paterson S, Fothergill JL, Wright EA, Ledson MJ, Walshaw MJ, Brockhurst MA, Winstanley C.
    Am J Respir Crit Care Med; 2011 Jun 15; 183(12):1674-9. PubMed ID: 21297072
    [Abstract] [Full Text] [Related]

  • 29. [Bacterial flora in mucoviscidosis in relation to the clinical picture].
    Duroś H, Gierowska H, Golebiowska H, Kunicka A, Nowakowska A, Rutkowski J.
    Przegl Epidemiol; 1972 Jun 15; 26(3):337-43. PubMed ID: 4628921
    [No Abstract] [Full Text] [Related]

  • 30. Convergent evolution and adaptation of Pseudomonas aeruginosa within patients with cystic fibrosis.
    Marvig RL, Sommer LM, Molin S, Johansen HK.
    Nat Genet; 2015 Jan 15; 47(1):57-64. PubMed ID: 25401299
    [Abstract] [Full Text] [Related]

  • 31. Eradication of Pseudomonas aeruginosa in cystic fibrosis.
    Eber E, Thalhammer GH, Zach MS.
    Eur Respir J; 2006 Feb 15; 27(2):438-9. PubMed ID: 16452606
    [No Abstract] [Full Text] [Related]

  • 32. Bacterial flora and ion content of cystic fibrosis sputum.
    Kilbourn JP.
    Pediatr Res; 1980 Mar 15; 14(3):259-60. PubMed ID: 6770327
    [No Abstract] [Full Text] [Related]

  • 33. Sensitivity of respiratory strains of Pseudomonas aeruginosa to carbenicillin.
    May JR, Ingold A.
    J Med Microbiol; 1973 Feb 15; 6(1):77-82. PubMed ID: 4632255
    [No Abstract] [Full Text] [Related]

  • 34. Selective oral decontamination in cystic fibrosis: an attempt to prevent pseudomonas colonisation.
    Dalzell AM, van Saene HK, Heaf DP.
    Acta Univ Carol Med (Praha); 1990 Feb 15; 36(1-4):40-1. PubMed ID: 2130715
    [No Abstract] [Full Text] [Related]

  • 35. Mycoflora in cystic fibrosis: some ecologic aspects of Pseudomonas aeruginosa and Candida albicans.
    Hughes WT, Kim HK.
    Mycopathol Mycol Appl; 1973 Jul 31; 50(3):261-9. PubMed ID: 4199669
    [No Abstract] [Full Text] [Related]

  • 36. [Etiology of the inflammatory process in chronic pneumonia and mucoviscidosis in children].
    Rachinskiĭ SV, Katosova LK, Sattorov GN, Shabalova LA.
    Pediatriia; 1984 Jan 31; (1):28-32. PubMed ID: 6424089
    [No Abstract] [Full Text] [Related]

  • 37. Persistence of Pseudomonas aeruginosa strains in seven cystic fibrosis patients followed over 20 months.
    Godard C, Plesiat P, Michel-Briand Y.
    Eur J Med; 1993 Feb 31; 2(2):117-20. PubMed ID: 8258014
    [No Abstract] [Full Text] [Related]

  • 38. Bacterial cyanogenesis occurs in the cystic fibrosis lung.
    Sanderson K, Wescombe L, Kirov SM, Champion A, Reid DW.
    Eur Respir J; 2008 Aug 31; 32(2):329-33. PubMed ID: 18480103
    [Abstract] [Full Text] [Related]

  • 39. [Serotyping of Pseudomonas aeruginosa strains from sputum of patients with cystic fibrosis].
    Bravo E, Letta MR, Amante A, Antonelli M.
    Ann Sclavo; 1983 Aug 31; 24(3):229-36. PubMed ID: 6412639
    [No Abstract] [Full Text] [Related]

  • 40. Interaction between Pseudomonas aeruginosa and Staphylococcus aureus: description of an anti-staphylococcal substance.
    Machan ZA, Pitt TL, White W, Watson D, Taylor GW, Cole PJ, Wilson R.
    J Med Microbiol; 1991 Apr 31; 34(4):213-7. PubMed ID: 1902262
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.